Conference Proceedings

BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma

Constantine S Tam, Quach Hang, Andrew Nicol, Xavier Badoux, Hannah Rose, H Miles Prince, Michael F Leahy, Richard Eek, Nicholas Wickham, Sushrut S Patil, Jane Huang, Xiaoping Zhang, Lai Wang, Eric Hedrick, William Novotny, Ian W Flinn

BLOOD | AMER SOC HEMATOLOGY | Published : 2017

Grants

Funding Acknowledgements

Quach: Amgen: Consultancy, Honoraria, Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria; Takeda: Consultancy, Honoraria. Badoux: Roche: Consultancy. Prince: Millennium Pharmaceuticals, Inc.: Consultancy, Membership on an entity's Board of Directors or advisory committees; Eisai: Membership on an entity's Board of Directors or advisory committees; Celgene Corporation: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited: Research Funding. Eek: Border Medical Oncology: Employment; Ramsey Private Hospital Albury Wodonga: Membership on an entity's Board of Directors or advisory committees. Huang: BeiGene: Employment. Zhang: BeiGene: Employment. Wang: BeiGene: Employment. Hedrick: BeiGene: Employment. Novotny: BeiGene: Employment. Flinn: Constellation: Research Funding; Curis: Research Funding; Gilead: Research Funding; Portola: Research Funding; Pharmacyclics: Research Funding; Trillium: Research Funding; KITE: Research Funding; Janssen: Research Funding; Calithera: Research Funding; Incyte: Research Funding; Agios: Research Funding; Infinity: Research Funding; Acerta: Research Funding; Celgene: Research Funding; Genentech: Research Funding; Janssen: Research Funding; Pharmacyclics LLC: Research Funding; Verastem: Research Funding; AbbVie Company: Research Funding; TG Therapeutics: Research Funding; Takeda: Research Funding; Seattle Genetics: Research Funding; Pfizer: Research Funding; Merck: Research Funding; Novartis: Research Funding; Beigene: Research Funding; Forty Seven: Research Funding.